KG
Insider
Kathryn Guarini
DirectorKathryn Guarini (Director) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Regeneron Pharmaceuticals, Inc. (REGN). The largest single filing was $340K of REGN (400 sh × $850.00, as filed), executed Sep 2.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
2
0 buys · 2 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$660K
shares × price, as filed
Last traded
Sep 2
Filed Sep 3
Median ADV $702.3M across their filed names
Open performance→Volume by month
Buys $0
Sells $660K
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
2 filings
Sector per market data · by filing · past 12 months
Most traded names
REGNRecent filings
REGNSALE
Regeneron Pharmaceuticals, Inc.
View filing →
$340K400 sh × $850.00
Exec Sep 2
Filed Sep 3 · 4:47 PM ET REGNSALE Regeneron Pharmaceuticals, Inc. View filing → $320K
400 sh × $800.00
Exec Aug 10
Filed Aug 12 · 4:16 PM ET